Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.trecan.2016.05.001 http://scihub22266oqcxt.onion/10.1016/j.trecan.2016.05.001 C5461962!5461962 !28603775     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=28603775 &cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\28603775 .jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       Trends+Cancer 2016 ; 2 (6 ): 313-324 Nephropedia Template TP {{tp|p=28603775 |t=2016. CRISPR/Cas9: From Genome Engineering to Cancer Drug Discovery |pdf=|usr=}}{{28603775 }} gab.com Text CRISPR/Cas9: From Genome Engineering to Cancer Drug Discovery JO: Trends Cancer http://www.kidney.de/pget.php?&tw=1&pmid=28603775 #FOAvip Advances in translational research are often driven by new technologies. The advent of microarrays, next-generation sequencing, proteomics and RNA interference (RNAi) have led to breakthroughs in our understanding of the mechanisms of cancer and the discovery of new cancer drug targets. The discovery of the bacterial clustered regularly interspaced palindromic repeat (CRISPR) system and its subsequent adaptation as a tool for mammalian genome engineering has opened up new avenues for functional genomics studies. This review will focus on the utility of CRISPR in the context of cancer drug target discovery. Twit Text FOAVip CRISPR/Cas9: From Genome Engineering to Cancer Drug Discovery ????Trends Cancer http://www.kidney.de/pget.php?&tw=1&pmid=28603775 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=28603775 #FOAvip English Wikipedia <ref>{{Cite pmid|28603775 }}</ref> CRISPR/Cas9: From Genome Engineering to Cancer Drug Discovery #MMPMID28603775 Luo J Trends Cancer 2016[Jun]; 2 (6 ): 313-324 PMID28603775 show ga Advances in translational research are often driven by new technologies. The advent of microarrays, next-generation sequencing, proteomics and RNA interference (RNAi) have led to breakthroughs in our understanding of the mechanisms of cancer and the discovery of new cancer drug targets. The discovery of the bacterial clustered regularly interspaced palindromic repeat (CRISPR) system and its subsequent adaptation as a tool for mammalian genome engineering has opened up new avenues for functional genomics studies. This review will focus on the utility of CRISPR in the context of cancer drug target discovery. |*Antineoplastic Agents [MESH] |*CRISPR-Cas Systems [MESH] |*Drug Discovery [MESH] |Animals [MESH] |Genetic Engineering [MESH] |Genome [MESH] |Humans [MESH]CRISPR/Cas9: From Genome Engineering to Cancer Drug Discovery (epmc).pdf DeepDyve Pubget Overpricing